FEE
Intelligence feed
Signal tape — company-linked filings & press, ranked by relevance
Sources healthyNewest data 17m ago
ON TAPE
30
30 company-linked
FILINGS
30
events · official
INSIDERS
0
PDMR prints
PRESS
0
company-linked news
30 signal items · filtered
ATTRIBUTED · DAY-GROUPED
MON 1 JUN8
SUN 31 MAY2
FRI 29 MAY8
- otherOFFICIALIssuer IR via MFN (press rooms)
AstraZeneca: CARES Phase III clinical programme did not meet primary endpoint in overall AL amyloidosis population, however, demonstrated anselamimab as potential first anti-fibril therapy in kappa AL amyloidosis
THU 28 MAY12